Carpal and tarsal bone development is highly sensitive to three antiproliferative teratogens in mice

Reproductive Toxicology

Volumn 10, Issue 6, 1996, Pages 485-489

  Rahman, Mohammed E ^a   Ishikawa, Hitoshi ^a   Watanabe, Yoshihiro ^a   Endo, Akira ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Ara C; busulfan; carpal and tarsal bones; MMC; neonatal mice; teratogenicity

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CHEMICAL TERATOGEN; CYTARABINE; MITOMYCIN C;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MALFORMATION; CARPAL BONE; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSSIFICATION; PERINATAL PERIOD; PREGNANCY; PRENATAL DEVELOPMENT; TARSAL BONE; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTINEOPLASTIC AGENTS; BUSULFAN; CARPAL BONES; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; MITOMYCIN; PREGNANCY; TARSAL BONES;

EID: 0030294416     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(96)00135-9     Document Type: Article

References (16)

1. 1. Rahman ME, Ishikawa H, Watanabe Y, Endo A. Carpal and tarsal bone anomalies in mice induced by maternal treatment of Ara-C. Reprod Toxicol. 1994;8:41-7.
2. 2. Rahman ME, Ishikawa H, Watanabe Y, Endo A. Stage specificity of Ara-C induced carpal and tarsal bone anomalies in mice. Reprod Toxicol. 1995;9:289-96.
3. 3. Endo A, Watanabe T. Interlitter variability in fetal body weight in mouse offspring from continuous, overnight, and short-period matings. Teratology. 1988;37:63-7.
4. 4. Fritz H, Hess R. Ossification of the rat and mouse skeleton in the perinatal period. Teratology. 1970;3:331-8.
5. 5. Dawson AB. A note on the staining of the skeleton of cleared specimens with alizarin red S. Stain Technol. 1926;1:123-5.
6. 6. Cook MJ. The anatomy of the laboratory mouse. London: Academic Press; 1965;43-51.
7. 7. Warkany J, Nelson RC, Schraffenberger E. Congenital malformations induced in rats by maternal nutritional deficiency. III. The malformations of the extremities. J Bone Joint Surg. 1943;25;261-70.
8. 8. Beck SL. Assessment of adult skeletons to detect prenatal exposure to 2,4,5-T or trifluralin in mice. Teratology. 1981;23:33-55.
9. 9. Maeda K. Skeletal malformations of the hand and foot in the rat fetus caused by maternal administration of myleran during pregnancy. Cong Anom. 1970;10:123-34.
10. 10. Chiba K, Rahman ME, Ishikawa H, Endo A. The timing of appearance of ossification centers of carpal and tarsal bones in mouse newborns. Cong Anom. 1995;35:189-97.
11. 11. Takehira Y, Shimamura K, Ishizaka K, Kameyama Y. Species differences of cytosine arabinoside induced poly-and oligodactylism in rat and mouse. Annu Rep Res Inst Environ Med Nagoya Univ. 1979;24:5-12.
12. 12. Inouye M, Kajiwara Y. Teratogenic interactions between methyl-mercury and mitomycin-C in mice. Arch Toxicol. 1988;61:192-5.
13. 13. Moreno PA, Epstein CJ. Enhanced susceptibility of mouse embryos heterozygous for oligosyndactyly (Os/+) to mitomycin C-induced skeletal abnormalities. Teratology. 1987;35:261-5.
14. 14. Endo A, Abe S, Imai Y, Ito T. Pilot study on the teratogenic effect exhibited by an anticarcinogenic agent (mitomycin C). Cong Anom. 1965;5:90-5 (in Japanese).
15. 15. Tanimura T. Effects of mitomycin C administered at various stages of pregnancy upon mouse fetuses. Okajimas Fol Anat Jap. 1968;44;337-55.
16. 16. Kameyama Y, Sugawara T, Ogawa T, Hoshino K, Murakami U. Effects of myleran on the development of the skeletal system in the rat and mouse embryos. Annu Rep Res Inst Environ Med Nagoya Univ. 1966;14:61-78.